What company is listed as AMGN on the Stock Exchange?
RATIOS/PROFITABILITY
- EPS (TTM) 9.71
- P/E (TTM) 20.68
- Fwd P/E (NTM) 11.90
- EBITDA (TTM) 12.393B
- ROE (TTM) 60.78%
- Revenue (TTM) 25.484B
- Gross Margin (TTM) 75.34%
- Net Margin (TTM) 22.55%
- Debt To Equity (MRQ) 397.50%
Will AMGN stock split?
Will Amgen split its stock again? It's possible. Amgen's stock has thumped the S&P 500 over the last decade and is currently trading within a few dollars of $200 per share. If the stock continues...
How much is Amgen stock worth?
With AMGEN stock trading at $249.87 per share, the total value of AMGEN stock (market capitalization) is $139.18B. AMGEN stock was originally listed at a price of $13.53 in Dec 31, 1997.
What are the most profitable stocks?
Paul Sankey, Sankey Research lead analyst, joins ‘Power Lunch’ to discuss how to play the rise in energy stocks, if the energy market’s profitability is sustainable and more.
See more
Is Amgen a buy sell or hold?
Amgen has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on 3 buy ratings, 10 hold ratings, and 1 sell rating.
Is AMGN a good stock?
Amgen Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of AMGN, demonstrate its potential to outperform the market. It currently has a Growth Score of A.
How much is Amgen?
$ 245.56CloseChgChg %$245.78-0.85-0.34%
Is Amgen profitable?
Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Amgen net profit margin as of March 31, 2022 is 21.75%....Compare AMGN With Other Stocks.Stock NameArcus Biosciences (RCUS)CountryUnited StatesMarket Cap$1.925BPE Ratio48.8013 more columns
Does Amgen stock pay dividends?
THOUSAND OAKS, Calif. , Dec. 3, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.94 per share dividend for the first quarter of 2022. The dividend will be paid on March 8, 2022 , to all stockholders of record as of the close of business on February 15, 2022 .
Should I buy AMGN Stockinvest?
Is Amgen Inc. stock A Buy? Amgen Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Is Amgen a stable company?
Amgen is a very good company to work for if you are looking for very good benefits and salary. Benefits, pay, culture, professionalism. Some of the best time off of any company in the biotechnology industry. Unstable environment at the present.
What happened today Amgen?
Amgen (AMGN) closed the most recent trading day at $246.63, moving -0.28% from the previous trading session.
What is Amgen best known for?
Amgen is one of the world's leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
What is Amgen's biggest drug?
Enbrel (etanercept) is one of Amgen's top-selling products. It is used to combat severe arthritis and similar inflammatory diseases.
Is Amgen growing?
Amgen is projecting compound annual growth in mid-single digits through the end of this decade. Considering the company reported 2021 revenue at $26 billion, that level of growth would get Amgen to roughly $35 billion in revenue in 2030.
Who is Amgen's biggest competitor?
Amgen competitors include Merck, Genentech, MedImmune, Genzyme and Celgene. Amgen ranks 1st in Gender Score on Comparably vs its competitors. See below how Amgen compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
Where is Amgen headquartered?
What is the Amgen valuation method?
Listed exchange for this security. NASDAQ. About. . . Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks , California, in 1980.
When will Amgen report its third quarter results?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
Did Amgen beat analysts' expectations?
Amgen (NASDAQ: AMGN) reported its third-quarter results on Nov. 2, 2021. In this Motley Fool Live video recorded on Nov. 3, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the highlights from the big biotech's Q3 update. A big biotech also announced Q3 results on Tuesday.
What is the ticker symbol for Amgen?
Amgen beat analysts' earnings expectations in the third quarter, and its balance sheet remains admirable.
How much of Amgen stock is held by institutions?
Amgen trades on the NASDAQ under the ticker symbol "AMGN."
What is the dividend payout ratio of Amgen?
74.95% of the stock of Amgen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
How much does Amgen make?
Amgen does not yet have a strong track record of dividend growth. The dividend payout ratio of Amgen is 42.41%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Amgen will have a dividend payout ratio of 39.09% next year.
Where is Amgen located?
Amgen has a market capitalization of $140.58 billion and generates $25.42 billion in revenue each year. The medical research company earns $7.26 billion in net income (profit) each year or $16.60 on an earnings per share basis.
What is Amgen's FY 2021 earnings?
Amgen's mailing address is ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA, 91320. The medical research company can be reached via phone at (805) 447-1000, via email at [email protected], or via fax at 805-447-1010.
When is Amgen earnings call?
Amgen updated its FY 2021 earnings guidance on Tuesday, November, 9th. The company provided EPS guidance of $16.500-$17.100 for the period, compared to the Thomson Reuters consensus estimate of $16.430. The company issued revenue guidance of $25.80 billion-$26.20 billion, compared to the consensus revenue estimate of $26.01 billion.
How many analysts have rated AMGN?
How can I listen to Amgen's earnings call? Amgen will be holding an earnings conference call on Tuesday, August 3rd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 404-537-3406 with passcode "1682169".
Who is Amgen Inc?
26 Wall Street analysts have issued ratings. Currently, 8 analysts rated AMGN as Bullish, 1 rated it Bearish, and 17 rated it Neutral. This suggests a possible increase. View AMGN’s analyst predictions. 9 Seeking Alpha authors also rated the stock, and their ratings often outperform those of Wall Street analysts. Here are their ratings on AMGN
Where is Amgen located?
Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels.
Is Amgen on the NASDAQ?
Amgen Inc.’s mailing address is One Amgen Center Drive, Thousand Oaks CA 91320-1799, United States . They can be reached by phone at 805 447 1000.
Is AMGN bullish?
Amgen Inc. is listed on the NASDAQ as (NASDAQ:AMGN).
How to calculate restricted stock?
26 analysts have issued ratings. Wall Street analysts rate AMGN as Bullish on average, for a Wall Street consensus of buy. View AMGN’s ratings here. 9 Seeking Alpha authors also rated the stock, and their ratings often outperform those of Wall Street analysts. Here are their ratings on AMGN
How long are futures trading delayed?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
What is trailing twelve month net income?
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
What is Amgen's main product?
A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding.
What time does AMC stock trade?
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acq
What is market cap?
AMC Entertainment Holdings, Inc. Class A Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices.
What is Amgen's specialty?
Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements.
Does market cap include convertible securities?
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases.
Sales
Risks
- 17 Wall Street analysts have issued 12 month price objectives for Amgen's stock. Their forecasts range from $179.00 to $232.00. On average, they anticipate Amgen's share price to reach $207.4706 in the next year. This suggests a possible upside of 20.7% from the stock's current price. View Analyst Price Targets for Amgen.
Ratings
- 17 Wall Street analysts have issued \"buy,\" \"hold,\" and \"sell\" ratings for Amgen in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of \"Hold.\" View Analyst Ratings for Amgen.
Reception
- Media stories about AMGN stock have trended somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most f…
Ownership
- Amgen's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.56%), Wells Fargo & Company MN (1.23%), LSV Asset Management (0.64%), Sumitomo Mitsui Trust Holdings Inc. (0.41%), Dimensional Fund Advisors LP (0.39%) and Parametric Portfolio Associates LLC (0.38%). Company insiders that own Amge…
Business
- Amgen has a market capitalization of $104.82 billion and generates $23.75 billion in revenue each year. The medical research company earns $8.39 billion in net income (profit) each year or $14.40 on an earnings per share basis. Amgen employs 21,500 workers across the globe.
Infrastructure
- Amgen's mailing address is ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA, 91320. The medical research company can be reached via phone at 805-447-1000 or via email at [email protected].